Taselisib T1999
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
CAS nr:
1282512-48-4
Purity:
98%
Molecular Weight:
460,53
SMILES:
CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O
Formula:
C24H28N8O2
Pathway:
PI3K/Akt/mTOR signaling,Metabolism
Target:
PI3K,Carbonic Anhydrase
